Speech-Language Pathologists in Michigan - Medicare Status, Address, Contact

3312 Speech-Language Pathologists found. Showing 81 - 100

Ms. Judy L Nantau, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 Catherine St, Ann Arbor, MI 48109 Phone: 734-764-8440

Mrs. Valerie Ericson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3135 Professional Dr, Ann Arbor, MI 48104 Phone: 734-677-4600

Ms. Georgiana Pacini Siehl, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1325 Franklin Blvd, Ann Arbor, MI 48103 Phone: 734-747-7717    Fax: 734-747-7711

Mrs. Rita Mcquade Ardan, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2511 White Tail Run Ct, Ann Arbor, MI 48105 Phone: 734-665-2043

Teresa H Lyden, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 E. Medical Center Dr., Spc 5312, 1904 Tc, Otolaryngology-head And Neck Surgery, Ann Arbor, MI 48109 Phone: 734-936-8051

Dr. Gordon Krainen, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 Catherine St, Ann Arbor, MI 48109 Phone: 734-764-8440

Sara Jane Acton, M.A., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3200 W Liberty Rd Ste F, Ann Arbor, MI 48103 Phone: 734-386-0308

Lisa Whitehead Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 East Catherine St., Ann Arbor, MI 48109 Phone: 734-764-8440

Andrea Renee Hanton, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-763-4003

Miss Adrianna Noel Spiteri, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-7080

Kathleen Paige Jurevicius, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2885 Sorrento Ave, Ann Arbor, MI 48104 Phone: 415-606-9456

Ms. Bailey A Blaisdell, M.A., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 Catherine St, Ann Arbor, MI 48109 Phone: 734-764-8440

Mrs. Caryn Hodrosky, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2830 S Main St, Ann Arbor, MI 48103 Phone: 440-935-1968

Marci Erin Rosenberg Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-7080

Jennifer Winstanley Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 E. Catherine, Ann Arbor, MI 48109 Phone: 734-764-8440    Fax: 734-647-2489

Emily Catherine Poole, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1540 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-232-7346

Mrs. Megan Schmuckel, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1540 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-232-8835

Keli Eileen Rulf Licata, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 Catherine St, Univ. Center For Development Of Language & Literacy, Ann Arbor, MI 48109 Phone: 734-764-8440

Lynn Driver, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-232-9261

Mrs. Megan Remenap, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4121 Jackson Rd, Ann Arbor, MI 48103 Phone: 734-263-2493

News Archive

Innovative vaccine therapy shows promise against glioblastoma brain tumors

An innovative vaccine therapy developed at Roswell Park Cancer Institute is being tested in a multisite clinical trial involving 50 patients with newly diagnosed glioblastoma brain tumors. The phase II study, now accruing patients at both Roswell Park and the Cleveland Clinic, will assess the effectiveness of the SurVaxM vaccine in combination with standard chemotherapy as treatment for this often-fatal cancer.

Onyx receives FDA approval for Kyprolis to treat multiple myeloma

The Multiple Myeloma Research Foundation (MMRF) today announced that its partner, Onyx Pharmaceuticals, Inc., received U.S. Food and Drug Administration (FDA) approval for Kyprolis (carfilzomib) for the treatment of patients with multiple myeloma who have received at least two prior therapies, including Velcade (bortezomib) for Injection and an immunomodulatory agent, such as Thalomid (thalidomide) or Revlimid (lenalidomide), and have demonstrated disease progression on or within 60 days of completion of the last therapy.

Despite economic slowdown, Central and Eastern European countries still represent an attractive healthcare market

Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market.

Endo enters into definitive agreement to acquire Grupo Farmaceutico Somar

Endo International plc today announced it has entered into a definitive agreement under which Endo will acquire Grupo Farmaceutico Somar, a leading privately-owned specialty pharmaceuticals company based in Mexico City, Mexico, for cash consideration. Endo expects the transaction to be immediately accretive to adjusted earnings per share.

States ask, answer questions on health law implementation

Even as some states didn't meet the target set by the Department of Health and Human Services for submitting their "benchmark" plans regarding the health law's essential health benefits, others offered specifics about what would be covered and what plans would be their choice.

Read more Medical News

› Verified 1 days ago

• 1
• 2
• 3
• 4
• 5(current)
• 6
• 7
• 8
• 9
• 10
• 11
• »